Lilly Settles Scores Of Zyprexa Suits

Law360, New York (June 12, 2007, 12:00 AM EDT) -- Eli Lilly & Co. has settled an additional 900 lawsuits surrounding its controversial anti-psychotic drug Zyprexa, a day after a judge denied the pharmaceutical giant's motion for summary judgment in three suits in the multidistrict product liability litigation.

The Indianapolis-based company revealed the settlement on Tuesday, marking the latest in a series of rapprochements reached in the thousands of cases involving Zyprexa, a medication used to treat schizophrenia and bipolar disorder.

For the past two years, Lilly has been under attack over the drug and its...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.